ArticleFrontiers in immunology2025

TMED9: a potential therapeutic target and prognostic marker in glioma and its implications across pan-cancer contexts.

Benyong Mi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.